Introduction:
Fujifilm Irvine Scientific announced plans to build a new manufacturing facility to accelerate the development in bioproduction, and cell and gene therapy markets in Tilburg, Netherlands.
Features:
This new facility will be the company’s third manufacturing site, joining two existing facilities in the United States and Japan.
The facility will occupy a 250,000 square foot building within FUJIFILM Manufacturing Europe B.V.
The facility is meant for cGMP manufacturing of animal component-free, dry powder media, liquid media, and downstream bioprocessing liquids, thereby adding additional production capacity for FUJIFILM Irvine Scientific of 320,000 Kg/year for dry powder, and 470,000 L/year for liquids. Water for Injection (WFI) will also be manufactured on the premises.
The construction work on the facility has commenced already and is expected to complete by the second half of 2021.
Specifications:
| Name | Fujifilm Irvine Scientific |
| Location | Tilburg, Netherlands |
| Type | Construction |
| Schedule | Scheduled to be completed by the second half of 2021 |
